Sizhe Yu

机构：Zhejiang Cancer Hospital, Hangzhou Cancer Hospital · ORCID：0000-0002-4446-2675

发表论文 21 篇 · 总被引 360 次 · h-index 10

代表论文

• Autophagy in the “inflammation-carcinogenesis” pathway of liver and HCC immunotherapy (2017 · Cancer Letters · 被引 70)
• A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma (2019 · Aging · 被引 37)
• Epithelial–mesenchymal transition induced cancer‐stem‐cell‐like characteristics in hepatocellular carcinoma (2019 · Journal of Cellular Physiology · 被引 35)
• Role of cancer‑associated fibroblasts in the resistance to antitumor therapy, and their potential therapeutic mechanisms in non‑small cell lung cancer (Review) (2021 · Oncology Letters · 被引 34)
• Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial (2025 · The Lancet Oncology · 被引 32)
• Efficacy of PD ‐1/ PD‐L1 inhibitors in patients with non‐small cell lung cancer and brain metastases: A real‐world retrospective study in China (2021 · Thoracic Cancer · 被引 31)